Silicon Valley Capital Partners Boosts Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Silicon Valley Capital Partners dramatically increased its position in Intuitive Surgical, acquiring an additional 17,919 shares, resulting in a total of 18,167 shares, valued at approximately $8.93 million.
• Multiple institutional investors also bolstered their stakes in Intuitive Surgical, indicating strong institutional interest with 83.64% of the company's stock now owned by insiders and hedge funds.
• Equities research analysts have given Intuitive Surgical a consensus rating of "Moderate Buy", with a price target averaging around $595.95, reflecting positive sentiment despite the stock's recent performance dip.

Silicon Valley Capital Partners increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7,225.4% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 18,167 shares of the medical equipment provider's stock after buying an additional 17,919 shares during the quarter. Intuitive Surgical comprises 1.2% of Silicon Valley Capital Partners' investment portfolio, making the stock its 26th biggest holding. Silicon Valley Capital Partners' holdings in Intuitive Surgical were worth $8,935,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Chilton Capital Management LLC raised its position in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares in the last quarter. Global Financial Private Client LLC increased its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares in the last quarter. Elite Financial Inc. purchased a new stake in Intuitive Surgical in the 1st quarter worth approximately $26,000. LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical in the 1st quarter worth about $30,000. Finally, TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 45 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In related news, insider Gary S. Guthart sold 29,360 shares of the firm's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 335 shares of the firm's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director owned 739 shares of the company's stock, valued at $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Citigroup reaffirmed a "buy" rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Evercore ISI raised their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Finally, UBS Group lifted their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Stock Down 3.8%

NASDAQ:ISRG opened at $449.98 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The stock's fifty day simple moving average is $489.31 and its 200-day simple moving average is $510.50. The firm has a market capitalization of $161.31 billion, a P/E ratio of 62.76, a P/E/G ratio of 4.90 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm's revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.78 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.